Albotherm develops temperature-responsive glass coatings that transition from transparent to white, effectively reducing solar gain in buildings and greenhouses without electrical input. This technology enables precise thermal regulation, addressing the significant energy consumption and greenhouse gas emissions associated with air conditioning in commercial buildings and agriculture.

Anaphite develops carbon nanotube-enhanced composite cathode powders for lithium-ion batteries, enabling direct dry coating without solvents or additives. This technology reduces energy consumption in electrode production while addressing the environmental impact of traditional wet dispersion methods.

BoobyBiome develops a probiotic supplement specifically designed for infants with compromised gut microbiomes, utilizing research on beneficial bacteria found in breast milk. This product addresses the health risks associated with low breastfeeding rates and underdeveloped microbiomes in infants, providing essential support for their digestive health.

Caudal Energy builds modular fin‑based tidal power systems that convert kinetic energy from moderate tidal currents into continuous, predictable electricity.

EnsiliTech utilizes a patented ensilication process to encase thermally unstable biomolecules within a silica network for enhanced stability. This technology eliminates the need for cold-chain logistics for vaccines, antibodies, and diagnostics, preventing spoilage and extending shelf-life across a wide temperature range. The method supports both new and existing biopharmaceutical formulations without relying on lyophilization or harsh processing conditions.

The startup develops a spectroscopy tool that analyzes protein conformations and biomolecular interactions under physiologically relevant conditions, providing real-time data analysis and visualization through cloud connectivity. This technology enables researchers in biophysics, life sciences, drug discovery, and medical diagnostics to gain insights into protein behavior, facilitating more effective scientific discoveries.

Halo Therapeutics develops highly targeted small molecule treatments using leading-edge deeptech health technologies. The company focuses on engineering breakthrough drugs with specific therapeutic intentions. This approach aims to deliver precise pharmacological effects for improved patient outcomes.

Healome Therapeutics is developing a proprietary eye drop technology that enhances drug retention, lubrication, and protection for patients with ocular surface diseases and injuries. Their approach aims to improve therapeutic outcomes and quality of life by reformulating existing ocular medications and creating novel treatments tailored to eye health challenges.

HotGreen provides commercially viable industrial high-temperature heat pumps that generate ultra-efficient green steam. Their patent-pending compressor technology enables industrial facilities to replace traditional boilers, reducing operational emissions and energy costs.

Lucida Medical provides Pi™, an AI‑driven decision‑support platform that analyzes prostate MRI scans to detect clinically significant cancers with sensitivity and specificity comparable to expert radiologists. By delivering real‑time risk scores, automated lesion segmentation, and standardized reports that integrate with existing PACS and RIS systems, Pi™ enables same‑day biopsy scheduling for high‑risk patients, reducing diagnostic delays, unnecessary procedures, and overall pathway costs.

MintNeuro designs and supplies purpose-built integrated circuits specifically for next-generation neural implants. These specialized semiconductors enable safer, smaller, and more power-efficient neurotechnology for sensing, stimulation, and wireless communication. The company partners with device makers and researchers to accelerate the development of scalable brain-computer interfaces and active implantable medical devices.

MitoRx Therapeutics develops first-in-class small molecule therapeutics that modulate mitochondrial metabolism to address cardiometabolic diseases, starting with obesity. Their platform utilizes targeted compounds to restore sulfide-signaling via enzymatic release within the mitochondria, reversing dysfunction. This approach aims to provide anti-obesogenic effects while preserving lean mass through adaptive metabolism restoration.

This startup develops an autonomous robot platform equipped with computer vision and machine learning to predict crop maturity and perform precision harvesting. By selectively harvesting labor-intensive crops, the technology minimizes damage and enhances local produce yield, ensuring freshness for farmers.

NexusAM provides a software platform that integrates real-time sensor data and artificial intelligence into metal additive manufacturing workflows. This technology accelerates part qualification timelines and significantly reduces inspection costs by identifying defects during the build process. The platform enables manufacturers in aerospace, medical, and energy sectors to achieve consistent, traceable quality for complex geometries at scale.

OSSTEC develops orthopedic implants utilizing biomimetic 3D printing technology for cementless fixation in joint replacement surgery. Their technology focuses on enhancing implant fixation to improve long-term outcomes and reduce loosening risks associated with current implants. This approach aims to simplify knee replacement procedures and support more active patient lifestyles.

OutSee develops computational algorithms for genomic analysis to identify therapeutic targets for precision medicine. The company enhances drug discovery by providing accurate insights into genetic variations that influence treatment efficacy.

QV Bioelectronics is developing Electric Field Therapy, which utilizes specific electrical frequencies to disrupt the growth cycles of glioblastoma cells, a highly treatment-resistant brain cancer. Their GRACE device aims to deliver continuous electric field therapy directly to tumor resection margins, targeting the area where most glioblastoma recurrences occur, thereby improving patient survival and quality of life.

Signapse is developing real-time Generative AI sign language translation software that provides seamless British Sign Language (BSL) and American Sign Language (ASL) interpretations for public announcements, videos, and websites. This technology addresses accessibility barriers for Deaf individuals, ensuring they receive accurate and engaging communication in environments where audio and written text are insufficient.

Silveray develops affordable large-area direct conversion detectors using patented semiconductor ink for the X-ray imaging market, enabling high-resolution imaging with lower radiation doses. Their flexible digital X-ray film (DXF) replaces traditional radiographic film and CR plates, facilitating efficient inspection of pipes and complex surfaces in industries such as aerospace and energy.

Transdermal Diagnostics has developed a 100% needle-free continuous glucose monitoring system that utilizes a disposable adhesive skin patch to extract biological substances through hair follicles. This technology provides a pain-free and cost-effective solution for individuals with diabetes, enhancing their ability to monitor blood glucose levels and manage their condition effectively.

WASE develops modular electro-methanogenic systems that enhance biogas production by 30% while reducing waste treatment time by 3 to 10 times. Their technology addresses the inefficiencies of traditional anaerobic digestion, providing a compact solution that improves effluent quality and minimizes operational costs for industries like agriculture and food processing.

Xgenera has developed a multi-cancer early diagnostic test that achieves 99% sensitivity and specificity across all cancer stages, enabling timely detection of cancer. This technology addresses the critical issue of late-stage cancer diagnoses, which significantly reduce survival rates, by providing a cost-effective solution for early intervention and treatment.